Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063361 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Clément Berthelot und 5 weiteren Autor:innen. Beteiligte Einrichtung: Childhood Cancer & Cell Death Team (C3 Team), LabEx DEVweCAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon (CRCL), Centr…. Hauptthemen laut MEDLINE: Glioma, Diffuse Intrinsic Pontine Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The BMP pathway is one of the major signaling pathways in embryonic development, ontogeny and homeostasis, identified many years ago by pioneers in developmental biology. Evidence of the deregulation of its activity has also emerged in many cancers, with complex and sometimes opposing effects. Recently, its role has been suspected in Diffuse Midline Gliomas (DMG), among which Diffuse Intrinsic Pontine Gliomas (DIPG) are one of the most complex challenges in pediatric oncology. Genomic sequencing has led to understanding part of their molecular etiology, with the identification of histone H3 mutations in a large proportion of patients. The epigenetic remodeling associated with these genetic alterations has also been precisely described, creating a permissive context for oncogenic transcriptional program activation. This review aims to describe the new findings about the involvement of BMP pathway activation in these tumors, placing their appearance in a developmental context. Targeting the oncogenic synergy resulting from this pathway activation in an H3K27M context could offer new therapeutic perspectives based on targeting treatment-resistant cell states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Childhood Cancer & Cell Death Team (C3 Team), LabEx DEVweCAN, Institut Convergence Plascan, Centre de Recherche en Cancérologie de Lyon (CRCL), Centre Léon Bérard, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 528…
- South-ROCK Pediatric Cancer Research Center, 69008 Lyon, France.
- Multisite Institute of Pathology, Groupement Hospitalier Est du CHU de Lyon, Hopital Femme-Mère-Enfant, 69677 Bron, France.
- Department of Translational Research in Pediatric Oncology PROSPECT, Centre Léon Bérard, 69008 Lyon, France.
- Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, 69008 Lyon, France.
ORCID-Profile: Clément Berthelot, Adrien Bertrand-Chapel, Pierre Leblond
Zitieren
APA
Berthelot, C., Huchedé, P., Bertrand-Chapel, A., Beuriat, P. A., Leblond, P., & Castets, M. (2024). Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063361
Vancouver
Berthelot C, Huchedé P, Bertrand-Chapel A, Beuriat PA, Leblond P, Castets M. Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063361
BibTeX
@article{Berthelot2024,
author = {Berthelot, Clément and Huchedé, Paul and Bertrand-Chapel, Adrien and Beuriat, Pierre-Aurélien and Leblond, Pierre and Castets, Marie},
title = {Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063361}
}
EUVIMED